Papierzewska, Małgorzata http://orcid.org/0000-0002-1919-5210
Waśkiel-Burnat, Anna http://orcid.org/0000-0003-4984-3589
Rudnicka, Lidia http://orcid.org/0000-0002-8308-1023
Article History
Accepted: 23 March 2023
First Online: 3 May 2023
Declarations
:
: No source of funding was used to conduct this review.
: Małgorzata Papierzewska—no conflicts of interest. Anna Waśkiel-Burnat)—no conflicts of interest. Lidia Rudnicka—medical lectures for Leo Pharma, Novartis, UCB Pharma; participation in advisory board meetings of Leo Pharma, Novartis, Pfizer, Sanofi, and UCB Pharma; participation in advisory board of the EMA.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Małgorzata Papierzewska: review, original draft, editing; Anna Waśkiel-Burnat: writing, review, editing; Lidia Rudnicka: concept, supervision, editing.